Sedulo crafted an early-warning monitoring program for a pharma leader focused on Parkinson’s stage therapies. Through secondary intelligence (press releases, clinical data) and primary interviews with competitor personnel, the team flagged key R&D moves, enabling the client to pivot proactively in a fast-evolving treatment space
